You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Hologic and LabCorp became the third and fourth commercial test makers to receive EUA designation for assays to detect the coronavirus that causes COVID-19.
In announcing a national emergency on Friday, Trump paraded out executives from the private sector as the administration tries to increase testing capacity
Firms like LabCorp, Quest, and BioReference have launched tests but a lack of clarity around demand presents challenges for assessing what capacity is needed.
LabCorp's test is being made available pursuant to FDA guidance that allows high-complexity, CLIA-certified labs to perform their own tests for SARS-CoV-2.
LabCorp will be the exclusive provider of the test, which uses next-generation sequencing to look for actionable mutations cell-free DNA in NSCLC patients.
Quest and LabCorp recently highlighted increased compensation costs while other industry observers have seen salaries rising for specialties like molecular.
Diagnostics revenues for the fourth quarter were $1.76 billion, up 4 percent from $1.69 billion in the same quarter last year.
The company said that it experienced a breach of an internal data system used by its integrated oncology business and that it is investigating the incident.
A pair of lawyers familiar with the case said that while ACLA might not win the legal battle, its lawsuit could aid efforts to get a legal fix to the law.
Abbott highlighted its next-generation Alinity platforms, and Caris discussed its plans to provide precision oncology services.